Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06504394
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-11
Brief Title:
A Study to Evaluate the Safety and Efficacy of Pembrolizumab MK-3475 Coformulated With Hyaluronidase MK-3475A in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma rrcHL or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma rrPMBCLMK-3475A-F65
Sponsor:
Organization:
None